phosphoserine has been researched along with linagliptin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Advani, A; Advani, SL; Batchu, SN; Klein, T; Liu, Y; Yerra, VG | 1 |
1 other study(ies) available for phosphoserine and linagliptin
Article | Year |
---|---|
The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Directly Enhances the Contractile Recovery of Mouse Hearts at a Concentration Equivalent to that Achieved with Standard Dosing in Humans.
Topics: Aging; Animals; Calcium Signaling; Diabetes Mellitus, Experimental; Diet, High-Fat; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Female; Heart; Humans; Linagliptin; Male; Mice, Inbred C57BL; Myocardial Contraction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Nitric Oxide; Perfusion; Phosphorylation; Phosphoserine | 2020 |